Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.Annette Martin, Marc Girard, James M. Hogle et al.|The EMBO Journal|1988Cited by 133
Characterization of persistent poliovirus mutants selected in human neuroblastoma cellsIsabelle Pelletier, Florence Colbère-Garapin, S. Borzakian et al.|Virology|1991Cited by 42
Molecular Pathogenesis of Neural Lesions Induced by Poliovirus Type 1Thérèse Couderc, F. Horaud, Christina Christodoulou et al.|Journal of General Virology|1989Cited by 41
Poliovirus permissivity and specific receptor expression on human endothelial cellsThérèse Couderc, R Crainic, Thérèse Barzu et al.|Virology|1990Cited by 18
Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deletedThérèse Couderc, R Crainic, Annette Martin et al.|Journal of General Virology|1991Cited by 13